Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bone Therapeutics S.A. | BOTHE | Apr 19, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 19, 2024 | 3.55 | -1.80 |
Brederode S.A. | BREB | Apr 19, 2024 | 109.80 | +0.55 |
Campine nv | CAMB | Apr 19, 2024 | 72.00 | +2.13 |
Candela Invest | CAND | Apr 19, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Apr 19, 2024 | 13.24 | +0.76 |
Celyad Oncology SA | CYAD | Apr 19, 2024 | 0.34 | +4.14 |
Cenergy Holdings | CENER | Apr 19, 2024 | 7.59 | +9.52 |
Chevron | CHTEX | Apr 19, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Apr 19, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Apr 19, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Apr 19, 2024 | 62.40 | +0.24 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Apr 19, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Apr 19, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Apr 19, 2024 | 41.38 | +0.98 |
Compagnie du Bois Sauvage S.A. | COMB | Apr 19, 2024 | 247.00 | -0.80 |
Compagnie d`Entreprises CFE SA | CFEB | Apr 19, 2024 | 7.40 | 0.00 |
Connect Group | CONN | Apr 19, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Apr 19, 2024 | 0.01 | -4.41 |
Cumulex NV | CLEX | Apr 19, 2024 | 1.15 | +9.52 |
CURETIS | CURE | Apr 19, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Apr 19, 2024 | 2.52 | -0.79 |
Deme Group N.V. | DEME | Apr 19, 2024 | 144.40 | -0.14 |
Deutsche Telekom AG | DTEL | Apr 19, 2024 | 20.00 | 0.00 |
Dexia SA | DEXB | Apr 19, 2024 | 0.30 | 0.00 |
Diegem KennedyCert | DIEG | Apr 19, 2024 | 123.00 | 0.00 |
Distri Land Le Certificat Foncier | DISL | Apr 19, 2024 | 210.00 | 0.00 |
DMS Imaging SA | ALIMG | Apr 19, 2024 | 0.02 | +8.25 |
DMS Imaging SA | DMSIM | Apr 19, 2024 | 0.02 | 0.00 |
D`ieteren Group | DIE | Apr 19, 2024 | 203.80 | -0.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.